HawkInsight

  • Contact Us
  • App
  • English

CFX briefly rose more than 10%, and its market value rose to US$387 million."

On July 1, or influenced by the news that "Pilot Pharmaceutical plans to acquire the entire equity of Conflux and the two parties have entered into a memorandum of understanding", CFX briefly rose more than 10%, and then fell back. It is now quoted at US$0.0788, and its market value rose to US$387 million.

Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.

NewFlashHawk Insight
More